Skip to main content

Jie Jin, MD, PhD

Jie Jin, MD, PhD
Videos
02/21/2024
Jie Jin, MD, PhD, shares results from a phase 2 study that explored the efficacy of Janus kinase inhibitor jaktinib treatment for ruxolitinib-intolerant patients with myelofibrosis.
Jie Jin, MD, PhD, shares results from a phase 2 study that explored the efficacy of Janus kinase inhibitor jaktinib treatment for ruxolitinib-intolerant patients with myelofibrosis.
Jie Jin, MD, PhD, shares results...
02/21/2024
Oncology